Drug Database
Back to search

United States· US:85248-150_571c961f-e343-e84a-e063-6394a90a4a7b

Gaayou Numbing

A medicinal product containing dibucaine hydrochloride, registered in United States by Jiangxi Yudexi Pharmaceutical Co., LTD.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGaayou NumbingATC—REGISTER NO.US:85248-150_571c961f…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dibucaine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DIBUCAINE HYDROCHLORIDE
Manufacturer
Jiangxi Yudexi Pharmaceutical Co., LTD
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    85248-150-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dibucaine hydrochloride in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dibucaine hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Cincain, Doloposterine N Salbe
  • Finland · Orodrops
  • Greece · Otaset
  • Italy · Cincocaina Cloridrato Allergeaze Smartpractice Europe
  • Portugal · Nupercainal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2fc42e39-c20c-45e6-9f90-e4e233293ca9
GET /v1/drugs/2fc42e39-c20c-45e6-9f90-e4e233293ca9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": ".5",
  "substance": "DIBUCAINE HYDROCHLORIDE",
  "productndc": "85248-150",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "strength_unit": "g/100g",
  "application_number": "M017",
  "marketing_category": "OTC MONOGRAPH DRUG"
}
API referenceMCP serverPlans

See everything about dibucaine hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console